A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...